Description
Introduction Of Soratib 200mg Tablet:
Soratib 200mg Tablet contains Sorafenib 200mg used to treat renal cell carcinoma (kidney cancer), Hepatocellular carcinoma (hepatic cancer), and Thyroid Cancer. It is not recommended in pediatric use
Benefits Of Soratib 200mg Tablet:
1. Renal cell carcinoma
It is a common type of kidney cancer found in adults. It is caused by obesity, smoking cigarettes, polycystic kidney disease, and some genetic condition. Symptoms include blood in urine, loss of appetite, weight loss, tiredness, and fever.
2. Hepatocellular carcinoma
It is also called malignant hepatoma, it is a common type of liver cancer. It usually occurs in people who are having a chronic liver disease such as cirrhosis, hepatitis B or C. Symptoms include weight loss, inflamed liver, loss of appetite, stomach pain, and jaundice
3. Thyroid cancer
Abnormal cell growth in the thyroid gland leads to the formation of tumor and cause cancer. Symptoms include a lump on your neck, change in your voice, pain in your neck and throat, inflamed lymph nodes in your neck, and difficulty in swallowing.
Mechanism Of Action Of Soratib 200mg Tablet:
Soratib 200mg Tablet contains Sorafenib 200mg is an anti-cancer medication, tyrosine kinase inhibitor. It produces its action by targeting several tyrosine kinase proteins present on surface receptors and intracellular structures of VEGF receptors, PDGF receptor, FGF receptor, cytokine receptor called as kit, IL 2 receptor, lymphocyte tyrosine kinase receptor, transmembrane tyrosine kinase receptor. In general, these receptors signal for angiogenesis and decrease apoptosis function. Sorafenib inhibits signals of angiogenesis and decreases the size of the tumor by starvation and increases apoptosis function.
Reviews
There are no reviews yet.